Guevara, N.; Maldonado, C.; Uría, M.; González, R.; Ibarra, M.; Alvariza, S.; Carozzi, A.; Azambuja, C.; Fagiolino, P.; Vázquez, M.
Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects. Pharmaceuticals 2017, 10, 73.
https://doi.org/10.3390/ph10030073
AMA Style
Guevara N, Maldonado C, Uría M, González R, Ibarra M, Alvariza S, Carozzi A, Azambuja C, Fagiolino P, Vázquez M.
Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects. Pharmaceuticals. 2017; 10(3):73.
https://doi.org/10.3390/ph10030073
Chicago/Turabian Style
Guevara, Natalia, Cecilia Maldonado, Manuel Uría, Raquel González, Manuel Ibarra, Silvana Alvariza, Antonella Carozzi, Carlos Azambuja, Pietro Fagiolino, and Marta Vázquez.
2017. "Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects" Pharmaceuticals 10, no. 3: 73.
https://doi.org/10.3390/ph10030073
APA Style
Guevara, N., Maldonado, C., Uría, M., González, R., Ibarra, M., Alvariza, S., Carozzi, A., Azambuja, C., Fagiolino, P., & Vázquez, M.
(2017). Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects. Pharmaceuticals, 10(3), 73.
https://doi.org/10.3390/ph10030073